Stock PBSV PHARMA-BIO SERV, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Pharma-Bio Serv, Inc.

Equities

PBSV

US71711N1000

Business Support Services

Delayed OTC Markets
Other stock markets
 14:56:59 26/06/2024 BST 		5-day change 1st Jan Change
0.648 USD +7.25% Intraday chart for Pharma-Bio Serv, Inc. -3.28% -38.29%
06-14 Tranche Update on Pharma-Bio Serv, Inc.'s Equity Buyback Plan announced on June 16, 2014. CI
06-14 Pharma-Bio Serv, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2024 CI

Valuation

Fiscal Period: October 2019 2020 2021 2022 2023 2024 2025
Capitalization 1 20.12 29.67 23.72 19.73 19.51 13.87 -
Enterprise Value (EV) 1 20.12 29.67 23.72 19.73 19.51 13.87 13.87
P/E ratio - - - - - - -
Yield - - - - - - -
Capitalization / Revenue 1.03 x 1.38 x 1.18 x 1.02 x 1.15 x 1.14 x 0.69 x
EV / Revenue 1.03 x 1.38 x 1.18 x 1.02 x 1.15 x 1.14 x 0.69 x
EV / EBITDA - - -6,273,546 x - - - -
EV / FCF - - - - - - -
FCF Yield - - - - - - -
Price to Book - - - - - - -
Nbr of stocks (in thousands) 22,996 23,002 23,029 22,944 22,963 22,958 -
Reference price 2 0.8750 1.290 1.030 0.8600 0.8497 0.6042 0.6042
Announcement Date 29/01/20 01/02/21 11/02/22 30/01/23 29/01/24 - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: October 2019 2020 2021 2022 2023 2024 2025
Net sales 1 19.51 21.56 20.12 19.4 16.98 12.2 20.2
EBITDA - - -3.781 - - - -
EBIT 1.697 - -3.854 - - - -
Operating Margin 8.7% - -19.16% - - - -
Earnings before Tax (EBT) - - - - - - -
Net income - - - - - - -
Net margin - - - - - - -
EPS - - - - - - -
Free Cash Flow - - - - - - -
FCF margin - - - - - - -
FCF Conversion (EBITDA) - - - - - - -
FCF Conversion (Net income) - - - - - - -
Dividend per Share - - - - - - -
Announcement Date 29/01/20 01/02/21 11/02/22 30/01/23 29/01/24 - -
1USD in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: October 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3
Net sales 1 4.238 4.563 4.577 3.598 - 2.378 3.5 4 5 5 5.1
EBITDA - - - - - - - - - - -
EBIT - - - - - - - - - - -
Operating Margin - - - - - - - - - - -
Earnings before Tax (EBT) - - - - - - - - - - -
Net income - - - - -0.2707 - - - - - -
Net margin - - - - - - - - - - -
EPS - - - - -0.0120 - - - - - -
Dividend per Share - - - - - - - - - - -
Announcement Date 17/03/23 14/06/23 14/09/23 29/01/24 18/03/24 14/06/24 - - - - -
1USD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: October 2019 2020 2021 2022 2023 2024 2025
Net Debt - - - - - - -
Net Cash position - - - - - - -
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow - - - - - - -
ROE (net income / shareholders' equity) - - - - - - -
ROA (Net income/ Total Assets) - - - - - - -
Assets - - - - - - -
Book Value Per Share - - - - - - -
Cash Flow per Share - - - - - - -
Capex - - 0.01 - - - -
Capex / Sales - - 0.05% - - - -
Announcement Date 29/01/20 01/02/21 11/02/22 30/01/23 29/01/24 - -
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Quarterly revenue - Rate of surprise

Company calendar

Sector Management Consulting Services

1st Jan change Capi.
PHARMA-BIO SERV, INC. Stock Pharma-Bio Serv, Inc.
-38.29% 13.87M
FTI CONSULTING, INC. Stock FTI Consulting, Inc.
+6.39% 7.52B
BAYCURRENT CONSULTING, INC. Stock BayCurrent Consulting, Inc.
-33.45% 3.06B
ICF INTERNATIONAL, INC. Stock ICF International, Inc.
+9.72% 2.77B
NIHON M&A CENTER HOLDINGS INC. Stock Nihon M&A Center Holdings Inc.
+11.17% 1.71B
SHANGHAI RESEARCH INSTITUTE OF BUILDING SCIENCES GROUP CO., LTD. Stock Shanghai Research Institute of Building Sciences Group Co., Ltd.
-21.53% 936M
ANHUI TRANSPORT CONSULTING & DESIGN INSTITUTE CO.,LTD. Stock Anhui Transport Consulting & Design Institute Co.,Ltd.
+0.45% 690M
FUNAI SOKEN HOLDINGS INCORPORATED Stock Funai Soken Holdings Incorporated
-9.63% 675M
THE HACKETT GROUP, INC. Stock The Hackett Group, Inc.
-5.58% 593M
STRIKE COMPANY,LIMITED Stock Strike Company,Limited
-2.70% 567M
Management Consulting Services
  1. Stock Market
  2. Equities
  3. PBSV Stock
  4. Financials Pharma-Bio Serv, Inc.